Journal articles on the topic 'Directors of the Poor'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Directors of the Poor.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Nowland, John, and Andreas Simon. "Is poor director attendance contagious?" Australian Journal of Management 43, no. 1 (2017): 42–64. http://dx.doi.org/10.1177/0312896217702426.
Full textMeiliana, Meiliana, and Iven Julia. "Analisis Pengaruh Struktur Dewan Direksi terhadap Kinerja Perusahaan." Global Financial Accounting Journal 6, no. 1 (2022): 170. http://dx.doi.org/10.37253/gfa.v6i1.6683.
Full textCarla, Juaçaba. "Pobre belleza = Poor beauty." rita_ Revista Indexada de Textos Académicos, no. 16 (October 31, 2021): 40–55. https://doi.org/10.24192/2386-7027(2021)(v16)(03).
Full textDandira, Martin. "Executive directors' contracts: poor performance rewarded." Business Strategy Series 12, no. 3 (2011): 156–63. http://dx.doi.org/10.1108/17515631111130121.
Full textLiu, Claire, Angie Low, Ronald W. Masulis, and Le Zhang. "Monitoring the Monitor: Distracted Institutional Investors and Board Governance." Review of Financial Studies 33, no. 10 (2020): 4489–531. http://dx.doi.org/10.1093/rfs/hhaa014.
Full textGrove, Hugh, Mac Clouse, and Tracy Xu. "Benchmarking boards of directors for better corporate governance." Corporate Board role duties and composition 16, no. 2 (2020): 8–18. http://dx.doi.org/10.22495/cbv16i2art1.
Full textHoitash, Udi, and Anahit Mkrtchyan. "Recruiting the CEO from the Board: Determinants and Consequences." Journal of Financial and Quantitative Analysis 53, no. 3 (2018): 1261–95. http://dx.doi.org/10.1017/s002210901800011x.
Full textSamin, Samin, and Satria Yudhia Wijaya. "IMPLIKASI KINERJA DAN INDEPENDENSI DEWAN DIREKSI TERHADAP KECENDERUNGAN PERUBAHAN STRATEGI PERUSAHAAN." Equity 18, no. 2 (2019): 105. http://dx.doi.org/10.34209/equ.v18i2.462.
Full textBurns, Natasha, Kristina Minnick, and Kartik Raman. "Director Industry Expertise and Voluntary Corporate Disclosure." Quarterly Journal of Finance 10, no. 03 (2020): 2050012. http://dx.doi.org/10.1142/s2010139220500123.
Full textAljaaidi, Khaled S., and Neef F. Alwadani. "Audit report delay: Does directors’ busyness matter?" Journal of Governance and Regulation 12, no. 3 (2023): 112–19. http://dx.doi.org/10.22495/jgrv12i3art12.
Full textVolpe, Virginia Olivia, Nicole D. Vincelette, Onyee Chan, et al. "High MYC Expression Predicts Poor Survival Outcomes in IDH1/2 Mutant AML Patients." Blood 138, Supplement 1 (2021): 2377. http://dx.doi.org/10.1182/blood-2021-147030.
Full textBorhan Uddin Bhuiyan, Md, and Jill Hooks. "Operational “problem” directors and environmental performance." Sustainability Accounting, Management and Policy Journal 7, no. 2 (2016): 268–94. http://dx.doi.org/10.1108/sampj-12-2014-0088.
Full textKhotchasing, Wassana, and Somchit Jaruratanasirikul. "Work Director’s Evaluation and Self-Evaluation of Professional Performance of Pediatricians Graduated from Prince of Songkla University." Songklanagarind Medical Journal 35, no. 3 (2017): 205. http://dx.doi.org/10.31584/smj.2017.35.3.730.
Full textLi, Zekun, Zhenping Chen, Xiaoling Cheng, et al. "Low-Dose Immune Tolerance Induction for Hemophilia a Children with Poor-Risk High-Titer Inhibitors." Blood 134, Supplement_1 (2019): 1122. http://dx.doi.org/10.1182/blood-2019-132021.
Full textPollyea, Daniel A., Keith W. Pratz, Andrew H. Wei, et al. "Outcomes in Patients with Poor-Risk Cytogenetics with or without TP53 Mutations Treated with Venetoclax Combined with Hypomethylating Agents." Blood 138, Supplement 1 (2021): 224. http://dx.doi.org/10.1182/blood-2021-145639.
Full textAgrawal, Anup, and Mark A. Chen. "Boardroom Brawls: An Empirical Analysis of Disputes Involving Directors." Quarterly Journal of Finance 07, no. 03 (2017): 1750006. http://dx.doi.org/10.1142/s2010139217500069.
Full textGuidez, Stéphanie, Guillemette Fouquet, Hélène Demarquette, et al. "Impact of Poor Tolerance and Discontinuation of the Dexamethasone during Treatment with Lenalidomide-Dexamethasone in Relapsed and Refractory Multiple Myeloma." Blood 126, no. 23 (2015): 5379. http://dx.doi.org/10.1182/blood.v126.23.5379.5379.
Full textMartello, Marina, Rosalinda Termini, Enrica Borsi, et al. "A Maturation Index Defines Newly Diagnosed Multiple Myeloma Patients with Advanced Immunophenotypic and Molecular Differentiation Profiles Associated with Poor Prognosis." Blood 134, Supplement_1 (2019): 1797. http://dx.doi.org/10.1182/blood-2019-129975.
Full textWhite, Susan, and Carlos J. O. Trejo-Pech. "Farmer Brothers Company Proxy Contest: A Corporate Governance Case Study." International Journal on Food System Dynamics 13, no. 1 (2022): 100–114. https://doi.org/10.18461/ijfsd.v13i1.a7.
Full textde Almeida, Jose Elias Feres. "An exploration of boards of directors’ quality: The development of an index for directors attributes and the relation with firm value and performance." Corporate Board role duties and composition 7, no. 2 (2011): 51–63. http://dx.doi.org/10.22495/cbv7i2art4.
Full textChan, Onyee, Najla Al Ali, Hammad Tashkandi, et al. "Mutations Highly Specific for Secondary AML Are Associated with Poor Outcomes in Patients with NPM1-Mutated ELN Favorable Risk AML." Blood 138, Supplement 1 (2021): 686. http://dx.doi.org/10.1182/blood-2021-150759.
Full textBelkhir, Mohamed. "Board of directors' size and performance in the banking industry." International Journal of Managerial Finance 5, no. 2 (2009): 201–21. http://dx.doi.org/10.1108/17439130910947903.
Full textJoffe, Erel, Anita Kumar, Serena Zheng, et al. "Genomic Profiling of Mantle Cell Lymphoma Suggests Poor-Risk Profile Is Present at Diagnosis and Does Not Arise By Tumor Evolution." Blood 134, Supplement_1 (2019): 22. http://dx.doi.org/10.1182/blood-2019-129563.
Full textNishat, Mohammed, and Rozina Shaheen. "Corporate governance and firm performance in an emerging market - An exploratory analysis of Pakistan." Corporate Ownership and Control 4, no. 2 (2007): 216–25. http://dx.doi.org/10.22495/cocv4i2c1p6.
Full textBarone, Gerhard, Kent Hickman, and Mark Shrader. "Board Changes in Response to Extremes in Performance." Journal of Finance Issues 10, no. 2 (2012): 24–29. http://dx.doi.org/10.58886/jfi.v10i2.2310.
Full textBhatnagar, Bhavana, Qiuhong Zhao, James L. Fisher, et al. "Poor Treatment Outcomes of Young (<60 Years) African American Patients (Pts) Diagnosed with Acute Myeloid Leukemia (AML) (Alliance)." Blood 136, Supplement 1 (2020): 5–7. http://dx.doi.org/10.1182/blood-2020-140999.
Full textPemmaraju, Naveen, Hagop M. Kantarjian, Joseph David Khoury, et al. "Outcomes in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Longer-Term Follow-up Demonstrates Poor Outcomes in Patients with Skin-Only Presentation." Blood 132, Supplement 1 (2018): 3980. http://dx.doi.org/10.1182/blood-2018-99-119888.
Full textLuo, Yi, Sheng Qiang He, Liang Jiang Wang, and Zong Bo Zhang. "Study on Ultrasonic Fusion Bonding for Polymer Microfluidic Chips." Key Engineering Materials 483 (June 2011): 311–15. http://dx.doi.org/10.4028/www.scientific.net/kem.483.311.
Full textStein, Guido, Manuel Gallego, and Marta Cuadrado. "CEO succession and proprietary directors: evidence from Spanish listed firms." Corporate Ownership and Control 11, no. 1 (2013): 140–46. http://dx.doi.org/10.22495/cocv11i1conf2p5.
Full textGrassi, Laura, Marco Giorgino, Raimondo Simona, and Giorgio Romani. "The induction of board directors: a case study perspective." Corporate Ownership and Control 13, no. 4 (2016): 207–23. http://dx.doi.org/10.22495/cocv13i4c1p6.
Full textGillman, L. M., A. Vergis, J. Park, and M. Taylor. "53. Resident training and the dictated operative report - A national perspectives." Clinical & Investigative Medicine 30, no. 4 (2007): 56. http://dx.doi.org/10.25011/cim.v30i4.2814.
Full textQian, Aimin, and Jingyan Li. "Effect of Appointed Directors on Corporate Carbon Emission Intensity: Evidence from Mixed-Ownership Reform in Chinese Private Industrial Enterprises." Sustainability 16, no. 13 (2024): 5662. http://dx.doi.org/10.3390/su16135662.
Full textShah, Parth, Anil Aktas-Samur, Mariateresa Fulciniti, et al. "Presence of Extrachromosomal DNA (ecDNA) Impacts Both Progression Free and Overall Survival and Is an Independent Poor Prognostic Marker in Multiple Myeloma." Blood 138, Supplement 1 (2021): 461. http://dx.doi.org/10.1182/blood-2021-151647.
Full textPadella, Antonella, Giovanni Marconi, Giorgia Simonetti, et al. "Higher Expression of PALB2 Predict Poor Prognosis in AML Patients and Identifies Potential Targets of Synthetic Lethal Therapies." Blood 132, Supplement 1 (2018): 1507. http://dx.doi.org/10.1182/blood-2018-99-118210.
Full textLabrador, Jorge, Miriam Saiz-Rodríguez, Maria Dunia De Miguel, et al. "Venetoclax Therapy in a Heavily Treated Cohort of Patients with Relapsed or Refractory Acute Myeloid Leukemia: Update of the Pethema Registry Experience." Blood 138, Supplement 1 (2021): 2325. http://dx.doi.org/10.1182/blood-2021-150231.
Full textBeattie, Vivien, Robin Roslender, and Sarah Jane Smith. "Balancing on a Tightrope: Customer Relational Capital, Value Creation and Disclosure." FINANCIAL REPORTING, no. 3 (June 2014): 19–52. http://dx.doi.org/10.3280/fr2013-003003.
Full textSharpe, Nicola. "Volkswagen's Bad Decisions & Harmful Emissions: How Poor Process Corrupted Codetermination in Germany's Dual Board Structure." Michigan Business & Entrepreneurial Law Review, no. 7.1 (2017): 49. http://dx.doi.org/10.36639/mbelr.7.1.volkswagen.
Full textBarwick, Benjamin G., Paola Neri, Nizar Bahlis, et al. "Immunoglobulin Lambda Translocations Identify Poor Outcome and IMiD Resistance in Multiple Myeloma and Co-Occur with Hyperdiploidy." Blood 132, Supplement 1 (2018): 405. http://dx.doi.org/10.1182/blood-2018-99-113585.
Full textSanyal, Abhijit, Joanna M. Hamilton, Ariel Martin, et al. "Using clinical pathways to prospectively identify poor prognosis cancer patients: A preliminary analysis." Journal of Clinical Oncology 39, no. 28_suppl (2021): 329. http://dx.doi.org/10.1200/jco.2020.39.28_suppl.329.
Full textKeane, Colm, Soi C. Law, Clare Gould, et al. "Elevated LAG-3 Expression in the Tumor Microenvironement of Patients with DLBCL Is Associated with a Non-GCB Phenotype and Poor Prognosis." Blood 132, Supplement 1 (2018): 1576. http://dx.doi.org/10.1182/blood-2018-99-112830.
Full textDerenzini, Enrico, Alessandra Rossi, Claudio Agostinelli, et al. "Integration of Nanostring Profiling and Functional Characterization of Oxidative and Replicative Stress Biomarkers Identifies Poor Prognosis MYC/BCL-2 Positive Diffuse Large B-Cell Lymphoma Subsets, Providing Opportunities for Precision Therapies." Blood 132, Supplement 1 (2018): 676. http://dx.doi.org/10.1182/blood-2018-99-118329.
Full textCegelka, Derek, Victoria R. Wagner-Greene, and Jennifer Newquist. "Health Behaviors of Funeral Directors in the US: A Needs Assessment." American Journal of Health Behavior 44, no. 6 (2020): 864–75. http://dx.doi.org/10.5993/ajhb.44.6.10.
Full textBertamini, Luca, Mariella Grasso, Mattia D'Agostino, et al. "Poor Prognosis of Multiple Myeloma Predicted By High Levels of Circulating Plasma Cells Is Independent from Other High-Risk Features but Is Modulated By the Achievement of Minimal Residual Disease Negativity." Blood 136, Supplement 1 (2020): 12–13. http://dx.doi.org/10.1182/blood-2020-137075.
Full textFleming, Shaun, Cheng-Hong Tsai, Hartmut Döhner, et al. "Use of Machine Learning in 2074 Cases of Acute Myeloid Leukemia for Genetic Risk Profiling." Blood 134, Supplement_1 (2019): 1392. http://dx.doi.org/10.1182/blood-2019-128243.
Full textKahan, Joseph B., Matthew Salzler, Danielle DiCenzo, Thomas Zink, Zachary Radford, and David Tybor. "High School Athletic Directors Report Poor Compliance With Concussion Reporting and Medical Clearance in Massachusetts." Arthroscopy, Sports Medicine, and Rehabilitation 2, no. 5 (2020): e563-e567. http://dx.doi.org/10.1016/j.asmr.2020.07.002.
Full textBhuiyan, Md Borhan Uddin, and Jamal Roudaki. "Related party transactions and finance company failure: New Zealand evidence." Pacific Accounting Review 30, no. 2 (2018): 199–221. http://dx.doi.org/10.1108/par-11-2016-0098.
Full textHertzberg, Mark S., Maher K. Gandhi, Belinda Butcher, et al. "Early Treatment Intensification with R-ICE Chemotherapy Followed By Autologous Stem Cell Transplantation (ASCT) Using Zevalin-BEAM for Patients with Poor Risk Diffuse Large B-Cell Lymphoma (DLBCL) As Identified By Interim PET/CT Scan Performed after Four Cycles of R-CHOP-14: A Multicenter Phase II Study of the Australasian Leukaemia Lymphoma Study Group (ALLG)." Blood 126, no. 23 (2015): 815. http://dx.doi.org/10.1182/blood.v126.23.815.815.
Full textOwie, Anggra Agastyassa, and Wahyu Utami Wati. "Optimalisasi Pelatihan Penyutradaraan untuk Meningkatkan Keterampilan dan Memperluas Peluang Masuk Dunia Kerja pada Anggota Teach4Hope di KitaBisa.com." Welfare : Jurnal Pengabdian Masyarakat 1, no. 4 (2023): 692–97. https://doi.org/10.30762/welfare.v1i4.998.
Full textPal, Jagannath, Jeffrey Sawyer, Samir B. Amin, et al. "Elevated Homologous Recombination Induces Karyotypic Changes and Predicts Poor Clinical Outcome In Multiple Myeloma." Blood 116, no. 21 (2010): 1924. http://dx.doi.org/10.1182/blood.v116.21.1924.1924.
Full textBall, Brian J., Christopher Famulare, Eytan M. Stein, et al. "Combined Venetoclax and Hypomethylating Agent (HMA) Therapy Induces High Response Rates in Patients with Myelodysplastic Syndrome Including Patients Previously Failing HMA." Blood 134, Supplement_1 (2019): 4241. http://dx.doi.org/10.1182/blood-2019-125113.
Full text